Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Not in Nasdaq Compliance Following Resignation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker is not in compliance with a Nasdaq regulation following the resignation of Collin D'Silva, an independent director and member of the firm's audit committee.

Bruker said in a filing with the US Securities and Exchange Commission on Friday that D'Silva had resigned his position on the audit committee as of March 9. As a result, the firm currently has only two members of its audit committee and is no longer in compliance with a Nasdaq rule that requires a company's audit committee to have a minimum of three members.

Bruker said that has until Sep. 7 to regain compliance with the Nasdaq rule, and added that it intends to fill the vacancy "as expeditiously as possible" prior to Sep. 7.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more